Brian D. Schwartz

Chief Medical Officer at ArQule, Inc.

Brian D. Schwartz

Brian D. Schwartz

Chief Medical Officer at ArQule, Inc.

Biography

Dr. Schwartz joined ArQule as Chief Medical Officer in July 2008 and in 2013 he took on the responsibility of head of research and development. Dr. Schwartz has more than a decade of experience in the pharmaceutical and biotechnology industries. Prior to joining ArQule, he was senior vice president, clinical and regulatory affairs, and chief medical officer at Ziopharm Oncology where he built and led the clinical, regulatory, and quality assurance departments with responsibilities for the development of new cancer drugs. Prior to Ziopharm, Dr. Schwartz held a number of positions at Bayer Healthcare. His experience in oncology encompassed the clinical development of novel cytostatic, cytotoxic and immunological agents. At Bayer, Dr. Schwartz was a key physician responsible for the global clinical development of sorafenib (Nexavar®) and led the clinical team through a successful Phase 3 trial in renal cell cancer, leading to U.S. Food and Drug Administration (FDA) approval. He has extensive regulatory experience working with the FDA’s Oncology Division, the European Medicines Agency (EMA), and numerous other health authorities. Dr. Schwartz has also been responsible for U.S. clinical and regulatory activities, including Phase 4 studies and interactions with the National Cancer Institute and other oncology cooperative groups. Dr. Schwartz received his medical degree from the University of Pretoria, South Africa, practiced medicine, and worked at the University of Toronto prior to his career in industry.

Overview
RelSci Relationships

80

Birthday

1962

Age

57

Relationships
RelSci Relationships are individuals Brian D. Schwartz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at ArQule, Inc.

Relationship likelihood: Strong

President & Chief Operating Officer at ArQule, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Treasurer at ArQule, Inc.

Relationship likelihood: Strong

Senior Director-Business Development at ArQule, Inc.

Relationship likelihood: Average

Senior Vice President, Head of Strategy, Finance & Communication at ArQule, Inc.

Relationship likelihood: Average

Vice President-Investor Relations & Corporate Communications at ArQule, Inc.

Relationship likelihood: Average

Former Chief Scientific Officer & Senior Vice President at ArQule, Inc.

Relationship likelihood: Average

Clinical Operations Director at ArQule, Inc.

Relationship likelihood: Average

Chief Executive Officer & Director at Faraday Pharmaceuticals, Inc.

Relationship likelihood: Average

Senior Vice President, Program Management & Product Planning at ArQule, Inc.

Relationship likelihood: Average

Paths to Brian D. Schwartz
Potential Connections via
Relationship Science
You
Brian D. Schwartz
Chief Medical Officer at ArQule, Inc.
Education
Class of 1985

University of Pretoria is a school.

Career History
Chief Medical Officer
2008 - Current

ArQule, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of targeted therapeutics to treat cancers and rare diseases. The company discovers, develops and commercializes novel small molecule drugs in areas of unmet need that will dramatically extend and improve the lives of its patients. Its proprietary pipeline includes ARQ 531, Derazantinib, Miransertib, ARQ 751, ARQ 761. The company was founded in 1993 and is headquartered in Burlington, MA.

Chief Medical Officer
2006 - 2008

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Brian D. Schwartz is affiliated with ArQule, Inc., Ziopharm Oncology, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Brian D. Schwartz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Brian D. Schwartz's profile does not indicate a business or promotional relationship of any kind between RelSci and Brian D. Schwartz.